Showing results (1131-1140 of 1,252) with videos related to

Sort By:
Pageof 126
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2006
Longitudinal analysis of clinical markers following antiretroviral therapy initiated during acute or early HIV type 1 infectionSigall Kassutto, Kaveh Maghsoudi, Mary N Johnston, et al.
AIDS (London, England)|April 25, 2022
High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/IPaul E Sax, Kristen Andreatta, Jean-Michel Molina, et al.
Cancer Research|July 28, 2012
MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cellsPrue N Plummer, Ruth Freeman, Ryan J Taft, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Methods of Information in Medicine|July 18, 2018
HiGHmed - An Open Platform Approach to Enhance Care and Research across Institutional BoundariesBirger Haarbrandt, Björn Schreiweis, Sabine Rey, et al.
Orvosi Hetilap|May 29, 2018
[Perioperative use of levosimendan in cardiac surgery. Hungarian recommendation]László Szudi, László Székely, Erzsébet Sápi, et al.
The Journal of Antimicrobial Chemotherapy|January 23, 2019
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353Amesika N Nyaku, Lu Zheng, Roy M Gulick, et al.
BMC Bioinformatics|December 18, 2020
Menoci: lightweight extensible web portal enhancing data management for biomedical research projectsM Suhr, C Lehmann, C R Bauer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 2, 2016
Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 ResultsDavid Wohl, Shinichi Oka, Nathan Clumeck, et al.
Oral Oncology|December 28, 2016
The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experienceAdepitan A Owosho, C Jillian Tsai, Ryan S Lee, et al.
Pageof 126